about
Validation of an algorithm to determine the primary care treatability of emergency department visits.The effectiveness of a health promotion program after 3 years: evidence from the University of Minnesota.Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events.Emergency department utilization as a measure of physician performance.Increased Computed Tomography Utilization in the Emergency Department and Its Association with Hospital Admission.Care of the dialysis patient: Primary provider involvement and resource utilization patterns - a cohort studyThe 3-year disease management effect: understanding the positive return on investment.Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use.Health Care Service Use Among Elderly Seasonal Migrators.Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection.Factors Associated with Emergency Department Utilization and Admission in Patients with Colorectal Cancer.Access to primary care and computed tomography use in the emergency department.Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort studyPediatric emergency medical services in privately insured patients: A 10-year national claims analysisRedefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of CareComputerized Clinical Decision Support System for Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: User-Centered DesignChronic use of tramadol after acute pain episode: cohort studyShift-Based Emotional Stress Reactions in Emergency Nurses After Traumatizing EventsIdentifying Opioid Use Disorder in the Emergency Department: Multi-System Electronic Health Record-Based Computable Phenotype Derivation and Validation Study
P50
Q37236816-E6514D67-2F19-4DF4-AD70-75CFF05A872AQ38017520-0612EEA4-DACD-43F8-8249-B50BCB21AB08Q38689948-E8D71F46-12A2-4541-A167-2BBAF70AB51CQ40112194-9660AA73-379C-4C01-9092-167D401E4A2FQ41560806-EBD12E34-C666-4250-891D-42E13D1B6F52Q42628143-D98D0284-E898-4F66-8FF2-74A2E3B0AAD9Q43737180-4EAFD814-1813-4B8B-81A1-C65FAF87E76DQ44349362-30DF2599-7892-415F-96F1-A0372D322FAAQ49376580-39D26052-B75A-42C4-A5C1-E876E9513F0EQ49663865-95D17BD7-296E-40C8-95AA-3304B5FA43BEQ50050600-35EDEA30-5770-4778-B436-B4E63FB21EE2Q51411208-8B2D782B-6216-4451-99BE-E8C4B7D951A4Q56514344-1E179958-1F33-41A1-A37A-5992A5936771Q58591966-7EE73A8E-C431-41CE-97EC-D49F166A516BQ63966143-C5CE5F49-B0D1-4024-A2BC-1BEDC627C879Q64096232-F7B8A6E7-1F95-4E37-8FB7-1C7A30B8C800Q64249206-5DBC8449-9072-4C22-9937-8FFF151B16E9Q90524372-AC2211B0-8C71-4402-B81D-98E1B40D75F3Q91053746-FC59839C-1A19-447A-A01B-33C6BB6B269C
P50
description
researcher, ORCID id # 0000-0003-3854-6810
@en
wetenschapper
@nl
name
Molly Moore Jeffery
@ast
Molly Moore Jeffery
@en
Molly Moore Jeffery
@es
Molly Moore Jeffery
@nl
type
label
Molly Moore Jeffery
@ast
Molly Moore Jeffery
@en
Molly Moore Jeffery
@es
Molly Moore Jeffery
@nl
prefLabel
Molly Moore Jeffery
@ast
Molly Moore Jeffery
@en
Molly Moore Jeffery
@es
Molly Moore Jeffery
@nl
P106
P108
P1153
55241354400
57194393406
P31
P496
0000-0003-3854-6810